89 / 148
87
(
`
cr)
NOTE 18 SHORT-TERM LOANS AND ADVANCES
As at
March 31, 2014
As at
March 31, 2013
Loans and advances, Unsecured, considered good to:
(a) Related parties
5.98
8.25
(b) Others:
(i) Advances recoverable in cash or kind
79.72
70.90
(ii) Balances with statutory authorities
16.18
23.48
(iii) Sundry deposits
0.66
0.83
102.54
103.46
(
`
cr)
NOTE 19 OTHER CURRENT ASSETS
As at
March 31, 2014
As at
March 31, 2013
(a) Export incentive receivable
34.29
16.91
(b) Mark-to-Market gains on derivatives
2.55
–
(c) Sundry receivable
Doubtful
0.19
0.19
Less: Provision for doubtful receivable
0.19
0.19
36.84
16.91
(
`
cr)
NOTE 20 REVENUE FROM OPERATIONS
2013-14
2012-13
Sale of products
2,457.12
2,085.66
Sale of services
0.89
1.39
Other operating revenue:
Export incentives
47.62
26.08
Scrap sales
4.94
6.38
Processing charges
5.48
3.76
2,516.05
2,123.27
Less: Excise Duty
150.60
121.79
2,365.45
2,001.48
(
`
cr)
DETAILS OF REVENUE
2013-14
2012-13
Sale of products
Life Science Chemicals
785.84
737.21
Performance and Other Chemicals
1,671.28
1,348.45
Gross revenue
2,457.12
2,085.66
Sale of services
0.89
1.39
Other operating revenue
58.04
36.22
2,516.05
2,123.27
Less: Excise duty
150.60
121.79
2,365.45
2,001.48
Notes
to the Financial Statements